Jim Simons Bluebird Bio, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,058,172 shares of BLUE stock, worth $370,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,058,172

Previous 791,504 33.69%

Holding current value

$370,360

Previous $775,000 29.03%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.47 - $1.35 $125,333 - $360,001	266,668 Added 33.69%	1,058,172 $550,000
Q2 2024 Aug 09, 2024	SELL	$0.85 - $1.26 $1.19 Million - $1.76 Million	-1,396,196 Reduced 63.82%	791,504 $775,000
Q1 2024 May 13, 2024	SELL	$0.91 - $1.75 $410,410 - $789,250	-451,000 Reduced 17.09%	2,187,700 $2.8 Million
Q4 2023 Feb 13, 2024	BUY	$1.32 - $4.83 $2.86 Million - $10.5 Million	2,163,800 Added 455.63%	2,638,700 $3.64 Million
Q3 2023 Nov 14, 2023	SELL	$3.02 - $4.05 $227,406 - $304,965	-75,300 Reduced 13.69%	474,900 $1.44 Million
Q2 2023 Aug 11, 2023	BUY	$2.79 - $5.03 $1.54 Million - $2.77 Million	550,200 New	550,200 $1.81 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $7.7 Million - $15.2 Million	-2,052,890 Reduced 73.06%	757,110 $4.79 Million
Q2 2022 Aug 12, 2022	BUY	$2.94 - $5.23 $5.5 Million - $9.78 Million	1,870,000 Added 198.94%	2,810,000 $11.6 Million
Q1 2022 May 13, 2022	BUY	$4.07 - $10.6 $3.83 Million - $9.96 Million	940,000 New	940,000 $4.56 Million
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $10 Million - $20.5 Million	-603,700 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$27.5 - $37.92 $10.7 Million - $14.8 Million	389,300 Added 181.58%	603,700 $26.1 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $7.38 Million - $9.38 Million	214,400 New	214,400 $11.6 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account